Amicus Therapeutics (NASDAQ:FOLD) Given “Equal Weight” Rating at Morgan Stanley
Amicus Therapeutics (NASDAQ:FOLD – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by research analysts at Morgan Stanley in a report released on Friday,Benzinga reports. They currently have a $12.00 target price on the biopharmaceutical company’s stock, down from their prior target price of $17.00. Morgan Stanley’s target price indicates a potential upside […]
More Stories
Eli Lilly and Company (NYSE:LLY) Shares Sold by Franklin Resources Inc.
Franklin Resources Inc. trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 3.7% in the third...
NanoViricides Holds 2024 Annual Meeting; Shareholder Proposals Approved ENDOTITLENanoViricides, Inc. recently convened its 2024 Annual Meeting of Stockholders on December 7, 2024. At the meeting, a substantial portion of the company’s voting stock wa
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Pine Valley Investments Ltd Liability Co Increases Stock Holdings in Salesforce, Inc. (NYSE:CRM)
Pine Valley Investments Ltd Liability Co boosted its position in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 14.0%...
Inspire Trust Co. N.A. Purchases 4,648 Shares of Alphabet Inc. (NASDAQ:GOOG)
Inspire Trust Co. N.A. lifted its position in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) by 32.4% in the...
1ST Source Bank Sells 1,685 Shares of General Electric (NYSE:GE)
1ST Source Bank cut its holdings in shares of General Electric (NYSE:GE – Free Report) by 13.7% during the 3rd...
Lowe’s Companies (NYSE:LOW) Given Neutral Rating at Wedbush
Wedbush restated their neutral rating on shares of Lowe’s Companies (NYSE:LOW – Free Report) in a research note issued to...